NPPB and chronic obstructive pulmonary disease: In practice, these biomarkers can be used to differentiate the symptoms caused by acute heart failure from COPD exacerbation, a BNP level of <100 pg/mL, and an NT pro BNP level of < 300 pg/mL, which makes acute decompensate heart failure very unlikely.